Publication | Open Access
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics
271
Citations
24
References
2003
Year
AsthmaInflammationAllergyLung InflammationAllergy MedicineImmunologyImmune RegulationBone MarrowMaturational ArrestImmune FunctionEosinophilic DisorderImmunotherapyMedicineAtopic AsthmaticsClinical Allergy
| Year | Citations | |
|---|---|---|
1992 | 2.8K | |
1990 | 2.5K | |
2000 | 1.8K | |
1993 | 1.4K | |
2003 | 804 | |
1988 | 521 | |
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. M.E. Rothenberg, J Petersen, R L Stevens, Clinical ImmunologyDirect ContactImmune RegulationImmunologyImmunologic Mechanism | 1989 | 284 |
1992 | 222 | |
1996 | 214 | |
1998 | 202 |
Page 1
Page 1